Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from Salsolinol-induced toxicity
- 13 March 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 340 (2) , 79-82
- https://doi.org/10.1016/s0304-3940(02)01461-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neuroprotective actions of selegilineJournal of Neuroscience Research, 2002
- Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s DiseaseNeurosignals, 2001
- Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brainNeuroscience, 2000
- Brain-derived Neurotrophic Factor Promotes Survival and Chemoprotection of Human Neuroblastoma CellsJournal of Biological Chemistry, 1999
- Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- The role of neuronal growth factors in neurodegenerative disorders of the human brainBrain Research Reviews, 1998
- NEUROTROPHINS AND THEIR RECEPTORS IN NERVE INJURY AND REPAIRNeurochemistry International, 1997
- Expression and Function of Recombinant Endothelial Nitric Oxide Synthase Gene in Canine Basilar ArteryCirculation Research, 1997
- Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolinesJournal of Medicinal Chemistry, 1990
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983